IMI - Clinical Myopia Management Guidelines report

Kate Gifford, Kathryn Richdale, Pauline Kang, Thomas Aller, Carly Lam, Y Maria Liu, Langis Michaud, Jeroen Mulder, Janis Orr, Kathryn Rose, Kathryn J Saunders, Dirk Seidel, Willem Tideman, Padmaja Sankaridurg

Research output: Contribution to journalArticlepeer-review

131 Downloads (Pure)


Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, optical and pharmacological treatments, as well as skills to translate the risks and benefits of a given myopia control treatment in lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable and the progressing myope, including risk factor identification, examination, selection of treatment strategies and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources and recommendations for continuing professional education in this growing area of clinical practice.
Original languageEnglish
Pages (from-to)M184-M203
JournalInvestigative Ophthalmology and Visual Science
Issue number3
Publication statusPublished (in print/issue) - 28 Feb 2019


  • Myopia control
  • myopia progression
  • clinical considerations
  • patient communication
  • practitioner education


Dive into the research topics of 'IMI - Clinical Myopia Management Guidelines report'. Together they form a unique fingerprint.

Cite this